Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Neoplasms of the CNS

  Free Subscription


23.11.2020

1 BMC Cancer
1 BMC Neurol
1 Cancer Res
1 Childs Nerv Syst
2 Clin Cancer Res
1 Clin Neuropathol
1 Eur J Cancer
1 J Neurol
14 J Neurooncol
1 J Neuropathol Exp Neurol
2 J Neurosurg
1 Nat Rev Cancer
1 Neurology
3 Neurosurgery
1 Oncogene
1 Pediatr Hematol Oncol
1 Pediatr Neurosurg
1 PLoS Genet


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. LI X, Meng Y
    Analyses of metastasis-associated genes in IDH wild-type glioma.
    BMC Cancer. 2020;20:1114.
    PubMed         Abstract available


    BMC Neurol

  2. YU Z, Huang B, Liang R
    Radiation-induced cavernous malformation after stereotactic radiosurgery for cavernous sinus meningioma: a case report.
    BMC Neurol. 2020;20:422.
    PubMed         Abstract available


    Cancer Res

  3. WU F, Zhang C, Zhao C, Wu H, et al
    Prostaglandin E1 Inhibits GLI2 Amplification-Associated Activation of the Hedgehog Pathway and Drug Refractory Tumor Growth.
    Cancer Res. 2020;80:2818-2832.
    PubMed         Abstract available


    Childs Nerv Syst

  4. TAN X, Wang Y, Jiang W, Cao Y, et al
    Paediatric supra- and infratentorial multiple giant clear cell meningioma: A report of a rare case and review of the literature.
    Childs Nerv Syst. 2020 Nov 20. pii: 10.1007/s00381-020-04975.
    PubMed         Abstract available


    Clin Cancer Res

  5. NAYAK L, Molinaro AM, Peters KB, Clarke JL, et al
    Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for recurrent glioblastoma patients.
    Clin Cancer Res. 2020 Nov 16. pii: 1078-0432.CCR-20-2500.
    PubMed         Abstract available

  6. VAZQUEZ-BORREGO MC, Gupta V, Ibanez-Costa A, Gahete MD, et al
    A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors.
    Clin Cancer Res. 2020;26:957-969.
    PubMed         Abstract available


    Clin Neuropathol

  7. ALZOUBI H, Maraqa B, Hasasna N, Giangaspero F, et al
    Diffuse midline glioma H3 K27M-mutant in adults: A report of six cases and literature review.
    Clin Neuropathol. 2020 Nov 16. pii: 187457. doi: 10.5414/NP301331.
    PubMed         Abstract available


    Eur J Cancer

  8. HONG AM, Waldstein C, Shivalingam B, Carlino MS, et al
    Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia.
    Eur J Cancer. 2020;142:10-17.
    PubMed         Abstract available


    J Neurol

  9. VAN KESSEL E, Huenges Wajer IMC, Ruis C, Seute T, et al
    Cognitive impairments are independently associated with shorter survival in diffuse glioma patients.
    J Neurol. 2020 Nov 19. pii: 10.1007/s00415-020-10303.
    PubMed         Abstract available


    J Neurooncol

  10. FERREIRA MSV, Sorensen MD, Pusch S, Beier D, et al
    Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    J Neurooncol. 2020;147:1-14.
    PubMed         Abstract available

  11. BETTE S, Gradtke CV, Cammardella JH, Albertshauser J, et al
    Perioperative neurocognitive functions in patients with neuroepithelial intracranial tumors.
    J Neurooncol. 2020;147:77-89.
    PubMed         Abstract available

  12. AMBADY P, Fu R, Szidonya L, Peereboom DM, et al
    Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma.
    J Neurooncol. 2020;147:171-176.
    PubMed         Abstract available

  13. CHAN RW, Chen H, Myrehaug S, Atenafu EG, et al
    Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.
    J Neurooncol. 2020 Nov 16. pii: 10.1007/s11060-020-03661.
    PubMed         Abstract available

  14. SONI P, Davison MA, Shao J, Momin A, et al
    Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03632.
    PubMed         Abstract available

  15. POETSCH L, Bronnimann C, Loiseau H, Frenel JS, et al
    Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
    J Neurooncol. 2020 Nov 17. pii: 10.1007/s11060-020-03662.
    PubMed         Abstract available

  16. FAN KY, Lalani N, LeVasseur N, Krauze A, et al
    Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.
    J Neurooncol. 2020 Nov 18. pii: 10.1007/s11060-020-03657.
    PubMed         Abstract available

  17. OLSON JJ, Ryken TC
    Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.
    J Neurooncol. 2020;150:87-93.
    PubMed         Abstract available

  18. LUNDY P, Domino J, Ryken T, Fouke S, et al
    The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:95-120.
    PubMed         Abstract available

  19. DOMINO JS, Ormond DR, Germano IM, Sami M, et al
    Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:121-142.
    PubMed         Abstract available

  20. VELAZQUEZ VEGA JE, Brat DJ, Ryken TC, Olson JJ, et al
    The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol. 2020;150:143-164.
    PubMed         Abstract available

  21. REDJAL N, Nahed BV, Dietrich J, Kalkanis SN, et al
    Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
    J Neurooncol. 2020;150:165-213.
    PubMed         Abstract available

  22. ZIU M, Kim BYS, Jiang W, Ryken T, et al
    The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol. 2020;150:215-267.
    PubMed         Abstract available

  23. FARRELL C, Shi W, Bodman A, Olson JJ, et al
    Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    J Neurooncol. 2020;150:269-359.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  24. ALSAFWANI N, Alrjoub M, Djuric U, Gao A, et al
    Tumor-Infiltrating Lymphocytes Are Enriched in Nonhypoxic Glioblastoma Niches.
    J Neuropathol Exp Neurol. 2020 Nov 19. pii: 5992386. doi: 10.1093.
    PubMed        


    J Neurosurg

  25. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
    Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
    J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
    PubMed         Abstract available

  26. YOO DH, Sohn CH, Cho YD, Kang HS, et al
    Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
    J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
    PubMed         Abstract available


    Nat Rev Cancer

  27. SETON-ROGERS S
    Closing in on cfDNA-based detection and diagnosis.
    Nat Rev Cancer. 2020;20:481.
    PubMed        


    Neurology

  28. STEGGERDA SJ, Tan RNGB, de Laat PCJ
    PHACE syndrome in a preterm infant.
    Neurology. 2020;95:751-752.
    PubMed        


    Neurosurgery

  29. JIN MC, Prolo LM, Wu A, Azad TD, et al
    Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma.
    Neurosurgery. 2020 Feb 28. pii: 5766369. doi: 10.1093.
    PubMed         Abstract available

  30. TAYLOR DG, Janssen A, Ding D, Xu Z, et al
    Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.
    Neurosurgery. 2019 Aug 5. pii: 5543991. doi: 10.1093.
    PubMed         Abstract available

  31. ABHINAV K, Nielsen TH, Singh R, Weng Y, et al
    Utility of a Quantitative Approach Using Diffusion Tensor Imaging for Prognostication Regarding Motor and Functional Outcomes in Patients With Surgically Resected Deep Intracranial Cavernous Malformations.
    Neurosurgery. 2019 Jul 30. pii: 5540733. doi: 10.1093.
    PubMed         Abstract available


    Oncogene

  32. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    PubMed         Abstract available


    Pediatr Hematol Oncol

  33. ABONGWA C, Cotter J, Tamrazi B, Dhall G, et al
    Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature.
    Pediatr Hematol Oncol. 2020;37:248-258.
    PubMed         Abstract available


    Pediatr Neurosurg

  34. AYDIN OZTURK P, Yilmaz T, Ozturk U, Aydin K, et al
    Pediatric Orbital Roof Intradiploic Meningioma Operated by Eyebrow Incision.
    Pediatr Neurosurg. 2020 Nov 18:1-4. doi: 10.1159/000511282.
    PubMed         Abstract available


    PLoS Genet

  35. LAFITA-NAVARRO MC, Venkateswaran N, Kilgore JA, Kanji S, et al
    Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
    PLoS Genet. 2020;16:e1009117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: